Close

Canaccord Genuity Raises Price target on Edwards Lifesciences (EW) as TAVI Continues to Grow

February 3, 2016 10:06 AM EST Send to a Friend
Canaccord Genuity reiterated a Buy rating on Edwards Lifesciences (NYSE: EW), and raised the price target to $92.00 (from $90.00) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login